Cargando…
miR-505 suppresses prostate cancer progression by targeting NRCAM
Previous researchers have demonstrated that microRNA-505 (miR-505) is negatively correlated with progression in various malignancies. However, the detailed function and molecular mechanisms of miR-505 have yet to be completely elucidated in prostate cancer (PCa). The present study initially identifi...
Autores principales: | Ling, Xiao-Hui, Fu, Hao, Chen, Zhi-Yun, Lu, Jian-Ming, Zhuo, Yang-Jia, Chen, Jia-Hong, Zhong, Wei-De, Jia, Zhenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667922/ https://www.ncbi.nlm.nih.gov/pubmed/31322225 http://dx.doi.org/10.3892/or.2019.7231 |
Ejemplares similares
-
miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020) -
KLF9 regulates miR-338-3p/NRCAM axis to block the progression of osteosarcoma cells
por: Liu, Yunlu, et al.
Publicado: (2022) -
MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R
por: Ren, Liang, et al.
Publicado: (2019) -
miR‐505 inhibits proliferation of osteosarcoma via HMGB1
por: Li, Guangzhang, et al.
Publicado: (2020) -
Cataracts and NrCAM
por: Dove, Alan W.
Publicado: (2001)